|
KIFAP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.5915999991617E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63509999984157E-08 |
| Normal-vs-Stage2 |
1.080620E-03 |
| Normal-vs-Stage3 |
4.294400E-01 |
| Normal-vs-Stage4 |
1.415920E-04 |
| Stage1-vs-Stage2 |
9.804400E-01 |
| Stage1-vs-Stage3 |
6.117900E-02 |
| Stage1-vs-Stage4 |
7.124400E-01 |
| Stage2-vs-Stage3 |
1.031380E-01 |
| Stage2-vs-Stage4 |
7.424400E-01 |
| Stage3-vs-Stage4 |
7.148300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.19839999946603E-07 |
| Normal-vs-AfricanAmerican |
5.6134999981694E-08 |
| Normal-vs-Asian |
3.484200E-01 |
| Caucasian-vs-AfricanAmerican |
2.042800E-01 |
| Caucasian-vs-Asian |
9.073400E-01 |
| AfricanAmerican-vs-Asian |
7.251800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.9293003012707E-10 |
| Normal-vs-Female |
1.087650E-01 |
| Male-vs-Female |
4.41240000004228E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.59639999999639E-05 |
| Normal-vs-Extreme_Weight |
7.1687000002818E-08 |
| Normal-vs-Obese |
3.940000E-03 |
| Normal-vs-Extreme_Obese |
1.544000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.474800E-01 |
| Normal_Weight-vs-Obese |
3.614000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.350200E-01 |
| Extreme_Weight-vs-Obese |
1.070050E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.928200E-01 |
| Obese-vs-Extreme_Obese |
4.521600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.150190E-01 |
| Normal-vs-Age(41-60Yrs) |
1.69556999999321E-05 |
| Normal-vs-Age(61-80Yrs) |
7.54310000017355E-08 |
| Normal-vs-Age(81-100Yrs) |
1.350000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.719200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.386000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.901640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.368000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.081000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.819800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.3327999814905E-09 |
| Normal-VS-Type2 PRCC |
3.418300E-02 |
| Normal-VS-KIRP CIMP |
1.354020E-01 |
| Normal-VS-Unclassified PRCC |
1.659580E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.283700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.070800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.407830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.033400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.415400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.932000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.615300E-04 |
| Normal-vs-N1 |
3.274200E-01 |
| Normal-vs-N2 |
9.315600E-01 |
| N0-vs-N1 |
1.245790E-01 |
| N0-vs-N2 |
2.337600E-01 |
| N1-vs-N2 |
7.089800E-01 |
|
|
